<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10867399</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Soler Vilarrasa, R</dc:author>
<dc:author>Tomás Barberán, M</dc:author>
<dc:author>Sarría Echegaray, P</dc:author>
<dc:author>Mas Mercant, S</dc:author>
<dc:author>Romaguera Lliso, A</dc:author>
<dc:description xml:lang="en">Pharyngocutaneous fistula is a serious complication of total laryngectomy. This problem increases morbidity, prolongs hospitalization, and occasionally causes death. Numerous contributing factors have been implicated in fistula formation (1). We propose that gastroesophageal reflux, which often is subclinical, is an important trigger and should be prevented. We evaluated the effect of associating an antireflux agent like metoclopramide hydrochloride to our usual ranitidine of our protocol after total laryngectomy on reducing the incidence (p&lt;0.05) of pharyngocutaneous fistula.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2000 Apr </dc:date>
<dc:title xml:lang="es">Profilaxis farmacológica del reflujo gastroesofágico. Incidencia de fístula faringocutánea tras laringuectomía total.</dc:title>
<dc:title xml:lang="en">[Pharmacological prophylaxis of gastroesophageal reflux. Incidence of pharyngocutaneous fistula after total laryngectomy].</dc:title>
<dc:publisher>Acta otorrinolaringologica espanola</dc:publisher>
</metadata>
</record>
</pubmed-document>
